Spyre Therapeutics, Inc. · NASDAQ:SYRE

Tang Capital Management LLC's stake in Spyre Therapeutics, Inc. fell to 2.40% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Tang Capital Management LLC's stake in Spyre Therapeutics, Inc. fell to 2.40%, 1,892,200 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
2.40%
Shares
1,892,200
Intent
Passive
What changed
Fell below 5%
Filed together
6 holders

The filing in full

HolderStakeShares
TANG CAPITAL MANAGEMENT, LLC2.40%1,892,200
KEVIN TANG2.40%1,892,200
TANG CAPITAL PARTNERS, LP1.30%1,012,338
TANG CAPITAL PARTNERS INTERNATIONAL, LP1.10%879,862
TANG CAPITAL PARTNERS III, INC0%0
TANG CAPITAL PARTNERS IV, INC0%0

Source

View original at SEC

Related